Table 1.
Subject characteristic | N | 5-year overall survival | |||
---|---|---|---|---|---|
Deaths | Rate (%) | P | |||
Age at diagnosis | <40 | 242 | 23 | 89.3 | |
40-49 | 2002 | 141 | 91.9 | ||
50-59 | 1489 | 134 | 88.6 | ||
>=60 | 1300 | 146 | 86.4 | <0.01 | |
Education | None | 190 | 30 | 78.8 | |
Elementary | 396 | 59 | 82.4 | ||
Middle or high school | 3642 | 313 | 90.0 | ||
College and above | 804 | 42 | 93.3 | <0.01 | |
Income* | <700 | 1403 | 165 | 87.0 | |
700-999 | 1484 | 148 | 88.0 | ||
1000-1999 | 1541 | 105 | 91.8 | ||
>=2000 | 602 | 26 | 93.4 | <0.01 | |
BMI | <25 | 3273 | 267 | 90.3 | |
25-29 | 1476 | 138 | 88.7 | ||
>=30 | 280 | 37 | 83.9 | 0.01 | |
Menopausal status | Pre | 2461 | 186 | 91.3 | |
Post | 2572 | 258 | 87.5 | <0.01 | |
Tamoxifen use | No | 2408 | 250 | 87.5 | |
Yes | 2622 | 193 | 91.1 | <0.01 | |
TNM | 0-II | 4318 | 280 | 91.9 | |
III-IV | 492 | 147 | 65.6 | ||
Unknown | 223 | 17 | 92.1 | <0.01 | |
ER status | ER- | 1772 | 224 | 85.2 | |
ER+ | 3181 | 202 | 92.0 | ||
Missing | 80 | 18 | 76.5 | <0.01 | |
PR status | PR- | 2043 | 238 | 86.0 | |
PR+ | 2894 | 187 | 92.1 | ||
Missing | 96 | 19 | 79.4 | <0.01 | |
Chemotherapy | No | 444 | 39 | 88.5 | |
Yes | 4589 | 405 | 89.5 | 0.95 | |
Radiotherapy | No | 3418 | 227 | 91.5 | |
Yes | 1615 | 207 | 84.9 | <0.01 | |
Radical mastectomy | No | 373 | 29 | 90.6 | |
Yes | 4660 | 415 | 89.3 | 0.77 | |
HRT use** | No | 2388 | 250 | 87.0 | |
Yes | 175 | 8 | 94.6 | 0.01 | |
Number of pregnancies | 0 | 202 | 21 | 88.7 | |
1 | 987 | 91 | 89.1 | ||
2 | 1669 | 120 | 91.7 | ||
3 | 1168 | 101 | 89.3 | ||
>3 | 1007 | 111 | 86.5 | 0.03 | |
Family history of cancer*** | No | 4728 | 423 | 89.3 | |
Yes | 305 | 21 | 91.1 | 0.29 | |
Co-morbidity score | 0 | 4031 | 341 | 90.1 | |
>=1 | 1002 | 103 | 86.7 | 0.06 |
Unit: (RMB/person/month), 1 USD=6.75RMB currently.
Among post-menopausal women
Family history of breast cancer or ovarian cancer